The above free vintage image of a scientist at work is courtesy of StockCake and Google Images.

As Gail Combs is apparently still in “locked out” mode for publishing posts (via WordPress, or **some other entity**), our host, Wolf Moon, gave the go-ahead for Yours Truly to do a Placeholder Open Thread for today. I am indebted to our host for this opportunity, as further information has surfaced regarding the role of the pangolin-CoV MP789 virus in the lab-creation of the SARS-CoV-2 (COVID-19) virus itself. Since today’s post concerns the COVID-19 virus itself, and the COVID-19 “vaccines”, it is dedicated to the memory of Yours Truly’s COVID-19 “vaccinated” brother Sam, and to her cousin Bill; and to all persons, of whatever age and location, who have passed away from the negative effects of the COVID-19 “vaccines” that they had in their bodies. However, the discussion is not limited to what is presented here: It is an Open Thread. Bear with me: there are a couple of surprising details coming up. There is a General Summary at the end of the post.

There are Important Wolf Moon Notifications, the Rules of our late, good Wheatie, and certain caveats from Yours Truly, of which readers should be aware. They are linked here.

To Begin: What will be called the “Part 1 Presentation” of the role of the PRRARSV genome code of the pangolin-CoV MP789 in the lab-creation of the SARS-CoV-2 virus itself is here: www.theqtree.com/2024/11/22/health-friday-11-22-2024-open-thread-lets-talk-about-prrarsv-the-backdoor-key/. Yours Truly presented evidence that: One: the pangolin-CoV MP789 virus genome code has “an uncanny similarity” to the PRRARSV genome code that was inserted into the genome code of the SARS-CoV-2 virus itself; Two: that this insertion occurred during the lab-creation process for the genome code of the SARS-CoV-2 virus itself; Three: that this insertion is at or very near the S1-S2 furin cleavage site in the genome code of the SARS-CoV-2 virus itself; Four: that the bat-coronavirus RaTG13 coronavirus also has a role to play in the lab-creation of the genome code of the SARS-CoV-2 virus itself, although the pangolin-CoV MP789 coronavirus genome code has more “areas of similarity” to the SARS-CoV-2 virus genome code; and, Five: that taxpayer-funded Gain-of-Function experiments were {most likely] used to perform all of the above, and most likely, at the Wuhan Institute of Virology.

In 2020, the year after the SARS-CoV-2 virus itself was beginning to ravage the world, and when COVID-19 “vaccines” had not yet been granted Emergency Use Authorizations by the FDA in the United States, by the EMA (European Medicines Agency), or by other agencies, a plethora of scientific papers and articles were written and published: papers and articles in which the researchers attempted to pinpoint exactly how the SARS-CoV-2 virus itself came into being. Many of these papers and articles examined the role(s) that various animal coronaviruses may have played in the emergence of the SARS-CoV-2 virus itself: for examples, by “natural evolution”; or, by “recombination” of coronavirus genomes among animals via cross-infection; or, by a “sudden appearance.” These investigations and their published results pre-date the confirmation within the past 18 months that Gain-of-Function experiments at lab facilities, most notably the Wuhan Institute of Virology, were the foundation of the lab-created disaster called the SARS-CoV-2 virus itself (links to Congressional reports on this situation are in the “Part 1 Presentation” Health Friday post, see above.) One such year 2020 scientific paper is the “Dimonaco, et al.” paper: https://pmc.ncbi.nlm.nih.gov/articles/PMC7823979/, “Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations”, Nicholas J. Dimonaco, et al., 30 December 2020. A screenshot of the Abstract of this paper is below:

The Health Friday post cited above discusses Yours Truly’s hypothesis that the pangolin-CoV MP789 coronavirus genome code was chosen, along with the important but actually less-similar bat coronavirus RaTG13 genome code, as the main virus genome that were used to create the SARS-CoV-2 virus itself genome. Today’s post, in Yours Truly’s opinion, presents evidence that “clinches the deal” on the choice of the pangolin-CoV MP789 genome code as the primary one for insertion into the SARS-CoV-2 virus itself genome code — however, the evidence comes from a surprising source.

The trail to this source begins here, an article by Stella Paul: https://brownstone.org/articles/why-are-hospitals-still-using-remdesivir/, 30 May 2023. The Paul article, in turn, was linked from this Vigilant Fox article: https://vigilantfox.news/p/9-shocking-covid-truths-theyll-never, 23 November 2024. This, in turn, led first, to here: www.fda.gov/consumers/consumer-updates/know-your-treatment-options-covid-19 (this article has no mention whatsoever of effective alternate treatment options for COVID-19, such as Ivermectin or Hydroxycholoquine); which, then, led to here: www.fda.gov/drugs/emergency-preparedness-drugs/coronavirus-covid-19-drugs. Which, in this last link, led to: mention of a “new” COVID-19 “pre-exposure” treatment drug that can only be used under certain circumstances, such as in persons with already-compromised immune systems; and only can be administered by infusion (IV): PEMGARDA, a monoclonal antibody treatment that also functions as an antiviral.

This is the link to the FDA-issued document for healthcare professionals for PEMGARDA: www.fda.gov/media/177067/download (note: PEMGARDA is also called Pemivibart in this document.) There have been no studies performed for PEMGARDA regarding carcinogenicity, mutagenicity, or impairment of fertility (section 13 Nonclinical Toxicology of the FDA document.) Persons who have been prescribed PEMGARDA need to take the infusion (IV) of the drug every 3 months (page 15 of the FDA document.) Also, PEMGARDA is not to be used as a “substitute” for COVID-19 “vaccination” (page 15 of the FDA document.) More details from the section Limitations of Authorized Use of the FDA document are below:

There is a slew of other warnings (including Black Box warnings), cautions, and restrictions regarding PEMGARDA in the FDA document.

Here is a screenshot of section 12.4 Mechanism of Action of the FDA document on PEMGARDA (aka Pemivibart):

**** And now, for the pangolin-CoV connection: This is found in the FDA document on PEMGARDA, Table 2. Yours Truly is including screenshots of Table 2., below. Please look at the screenshots carefully. There are seven screenshots. This is the list of SARS-CoV-2 variants that PEMGARDA is ** allegedly ** supposed to help “guard against.” The bottom line here is: Virtually every SARS-CoV-2 variant is derived from a pangolin-CoV genome code (most likely that of pangolin-CoV MP789) that was “blended in” along with the bat-CoV RaTG13 genome code in the lab-creation of the original SARS-CoV-virus itself. The giveaway is “Pango lineage” at the top of the variants columns. (Note: due to screenshot size constraints, some of the variant lists are broken up: however, EVERY variant column clearly states Pango lineage at the top left.)

The question that comes to mind is: Why is PEMGARDA being promoted as a “pre-exposure prophylaxis” against a COVID-19 infection in immunocompromised persons; or, for that matter, for any person, COVID-19 “vaccinated” or not? The answer is that the FDA still does not recognize, authorize, or recommend, the use of Ivermectin, Hydroxycholorquine, Zinc, Quercetin, Vitamin D, or other “non-FDA-authorized or approved” drugs or treatments for prophylaxis for COVID-19 infection; or for COVID-19 infection treatment. While there may be need for PEMGARDA to be used for certain patients in narrow circumstances, it is Yours Truly’s opinion that it is vastly less expensive and effective to use Ivermectin, Hydroxycholorquine, Zinc, Quercetin, and Vitamin D in the large majority of situations to prevent infection by COVID-19.

Then, there is the issue of what Yours Truly will call “Universal Immune System Compromise from COVID-19 Vaccination.” It is her firm opinion that any person who has ever taken a COVID-19 “vaccine” has a compromised immune system. This is due to the ingredients and the mechanisms of the COVID-19 “vaccines” themselves; in which the critical IgG3 “fight it off” immune system cells of the “vaccinated” person are damaged and/or destroyed, and the growth of IgG4 “tolerate but never clear” cells is increased. This process increases with each successive COVID-19 “vaccine booster” injection (which would include injections of the “latest version” of said “vaccines.”) Please see: https://jessicar.substack.com/p/igg4-cd4s-and-why-the-lnpmrna-platform, “IgG4, CD4s and why the LNP/mRNA platform should be prohibited”, by Jessica Rose, Ph.D., 14 August 2023.

PEMGARDA (aka Pemivibart) is an expensive drug. For example, below is a screenshot from www.patientpower.info/ regarding the cost per treatment for PEMGARDA. This is the non-insurance covered cost:

Recall that the FDA document on PEMGARDA cited above states that persons who are prescribed to take this drug need to repeat the treatment every 3 months.

General Summary: One: Yours Truly presented the first of the hypothesis regarding the use of the pangolin-CoV MP789 in the lab-creation of the original SARS-CoV-2 virus itself (the original Wuhan Hu1 COVID-19 virus itself) in the Health Friday post of 15 November 2024. Two: there is a large amount of scientific papers and articles published in 2020, with researchers investigating various hypotheses regarding a “combination” of animal coronaviruses in nature that produced the original SARS-CoV-2 virus itself. This research was performed prior to the confirmation that the SARS-CoV-2 virus itself was the product of Gain-of-Function lab-creation, most likely at the Wuhan Institute of Virology, using coronaviruses from various animals, including the bat-CoV RaTG13 and the pangolin-CoV MP789. Four: the pangolin-CoV MP789 virus genome has the “closest overall match similarity” to the genome of the SARS-CoV-2 virus itself. Five: there is a new FDA “pre-exposure prophylaxis and antiviral” drug, PEMGARDA, that is administered by infusion (IV) only, and only for certain types of immunocompromised persons. Six: the FDA-issued Fact Sheet for PEMGARDA clearly shows, in Table 2. of the document, that the SARS-CoV-2 variants that PEMGARDA is to “guard against” are virtually all derived from what the document states is “Pango lineage.” Seven: the FDA still does not recognize, authorize, or approve, of the use of Ivermectin, Hydroxycholorquine, and other effective alternatives for COVID-19 infection prevention or treatment.

Peace, Good Energy, Respect: PAVACA